Gremlin is an inhibitor in the TGF beta signaling pathway. It primarily inhibits bone morphogenesis and is implicated in disorders of increased bone formation and several cancers. From Wikipedia
The Nature study validates SPP1 in preclinical models, with drug discovery now the next step.
